Country: United Arab Emirates
Related Posts
The Mideast’s Travel and Hospitality Industry Has a Lot at Stake in the WHO’s Impending Ruling on Chinese Vaccines
Representatives from the Mideast's travel industry are closely watching their news feeds for any updates on the World Health Organization's impending decision as to whether or not to grant emergency use approval to Chinese-made COVID-19 vaccines Sinopharm and Sinovac. Currently, the ...
Deals, Deals & More Deals. China’s Tech Giants Expand in Africa & the Middle East
2021 has been a busy year so far for China's technology giants as they look to expand their international operations and appear to have their sites set on expanding in both the African and Arabian markets. JD, Didi, iQiyi, and Tencent ...
E-Commerce Giant JD.com Is the Latest Chinese Tech Company to Expand in the Middle East
China's second-largest e-commerce company, JD.com, is looking to high-end fashion consumers in the Persian Gulf as part of a new expansion in the Middle East. JD signed a partnership agreement with Namshi (photo), the fashion and lifestyle platform owned by Dubai’s ...
Tech Digest: With China’s Tech Giants Increasingly Shut Out of the EU & U.S., Africa Now Looks a Lot More Appealing
Oversaturation in China’s domestic tech market and a pandemic-fuelled cash crunch are driving Chinese firms to expand their African ventures. As 2021’s first quarter comes to a close, let’s take stock of the scoreboard: ...
China Wants to Be a Big Player in the Middle East
Chinese Foreign Minister Wang Yi's latest six-nation tour of the Middle East and Turkey revealed that Beijing now aims to play a much larger role in the region. During his trip, Wang signed a high-profile ...
UAE to Become First Country Outside of China to Manufacture Sinopharm COVID-19 Vaccines
Chinese Foreign Minister Wang Yi closed out his Persian Gulf tour on Sunday with a major announcement that the United Arab Emirates would become the first country outside of China to manufacture the widely-distributed Sinopharm COVID-19 vaccine, making the UAE the first country in the region to ...
From Africa to Asia to the Americas and Even Europe, Countries Scramble for Chinese-Made COVID-19 Vaccines
Countries across the Global South and now even in Europe scrambled this weekend to source COVID-19 vaccines from pretty much anywhere they could buy them -- which in many cases brought them to China's doorstep. Amid widespread shortages, the European Union ...
The Full Picture: China, Africa, and the Global South
The last year has seen the China-Africa space undergoing massive changes. The impacts of COVID-19, the pandemic-induced debt crisis and rapid shifts in Chinese financing to Africa have shifted some of the core assumptions underlying what we think of as ‘China-Africa relations.’
China’s COVID-19 Vaccine Rollout Gains Momentum in Many Developing Regions
There's been a flurry of activity on the Chinese vaccine distribution front. Over the weekend, a growing number of countries across the Global South are taking delivery of Chinese-made COVID-19 vaccines even before they completed clinical trials or received WHO pre-qualification. ...
China’s Growing Influence in the Mideast & Persian Gulf
China is steadily reducing its dependence on African oil suppliers who once accounted for a third of Chinese crude imports. Today, China buys more oil from Saudia Arabia than any other country in the world. From 2019 to 2020,
China’s Closing More Deals to Distribute COVID-19 Vaccines, But None So Far in Sub-Saharan Africa
The list of countries signing up to procure Chinese-made COVID-19 vaccines is growing, largely in developing countries, according to the U.S. news site Axios. While there are two African countries on the list, Egypt and Morocco, it's notable that so far no sub-Saharan ...
With UAE Approval, China’s COVID-19 Vaccines Make Their Official International Debut
The United Arab Emirates on Wednesday became the first foreign country to officially approve the use of a Chinese-made COVID-19 vaccine. UAE's health ministry reported that the vaccine made by Sinopharm was 86% effective in phase 3 clinical trials.